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Abstract
Background: Carnosic acid (CA) and rosemary extracts (RE) show body-weight, energy metabolism and inflammation
regulatory properties in animal models but the mechanisms are not yet understood. Gut microbiota plays an important role
in the host metabolism and inflammatory status and is modulated by the diet. The aim of this research was to investigate
whether a RE enriched in CA affected caecum microbiota composition and activity in a rat model of genetic obesity.
Methods and Principal Findings: A RE (40% CA) was administered with the diet (0.5% w/w) to lean (fa/+) and obese (fa/fa)
female Zucker rats for 64 days. Changes in the microbiota composition and b-glucosidase activity in the caecum and in the
levels of macronutrients and short chain fatty acids (SCFA) in feces were examined. The RE increased the Blautia coccoides
and Bacteroides/Prevotella groups and reduced the Lactobacillus/Leuconostoc/Pediococccus group in both types of animals.
Clostridium leptum was significantly decreased and Bifidobacterium increased only in the lean rats. b-Glucosidase activity was
significantly reduced and fecal fiber excretion increased in the two genotypes. The RE also increased the main SCFA
excreted in the feces of the obese rats but decreased them in the lean rats reflecting important differences in the uptake
and metabolism of these molecules between the two genotypes.
Conclusions: Our results indicate that the consumption of a RE enriched in CA modifies microbiota composition and
decreases b-glucosidase activity in the caecum of female Zucker rats while it increases fiber fecal elimination. These results
may contribute to explain the body weight gain reducing effects of the RE. The mutated leptin receptor of the obese
animals significantly affects the microbiota composition, the SCFA fecal excretion and the host response to the RE intake.
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Introduction
Obesity and metabolic syndrome are increasingly common
worldwide disorders attributed to excessive consumption of
energy-dense foods, sedentary habits and genetic background
[1,2]. Impaired energy metabolism and low-grade inflammation
are common characteristics of these disorders. The gut microbiota
is also a key contributor to the development of obesity and
metabolic disorders since it can modulate host energy metabolism
and inflammatory status [3,4]. Intestinal microbiota is mostly
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composed of anaerobic microbes distributed in two predominant
phyla: Firmicutes (Ruminococcus, Clostridium, Eubacterium, Lactobacil-
lus) and Bacteroidetes (Alistipes, Prevotella, Bacteroides) with significant
numbers of Actinobacteria (Bifidobacterium) and Proteobacteria
members [5,6]. The intestinal microbiota plays an important role
in fermenting and converting non-digested nutrients (i.e. resistant
starch, fiber) into nutrients to provide further energy [5,7]. This
ability is sustained by the production of an array of enzymes
including glycoside hydrolases that catalyze the breakdown of
carbohydrates to fermentable monosaccharides [6]. b-Glucosidas-
es are a family of glucohydrolases that act upon b1R4 bonds and
contributes to the hydrolysis and fermentation of cellulose. The
main end products of fermentation by the microbiota are short-
chain fatty acids (SCFA), typically acetate, propionate and
butyrate which are largely absorbed and metabolized by the host
organism. SCFA can act as signaling molecules and regulate
energy metabolism and inflammatory responses in the host [8].
They also play important roles as substrates for glucose, cholesterol
and lipid metabolism providing up to 10% of the daily caloric
intake [9]. Microbial metabolism can also affect gut-hormone
production and intestinal permeability causing elevated systemic
levels of lipopolysaccharide which contributes to the low-grade
systemic inflammation associated with obesity and metabolic
syndrome [10].
Obesity is associated with changes in the abundance at the level
of phylum, genus or species of gut microbiota. In mice, Firmicutes
is increased and Bacteroidetes decreased in obese animals [3] but,
in humans, differences between obese and normal-weight individ-
uals as well as changes following weight reduction due to caloric-
restriction are not consistent [5]. It does appear, however, that the
mutual influence of gut flora composition and overall weight
conditions is connected to differences in the energy-reabsorbing
potential of different ratios of Firmicutes and Bacteroidetes,
especially in the digestion of dietary fats and carbohydrates
[11,12]. Modulation of the gut microbiota through the diet to
enhance host health and to reduce the incidence of obesity and
associated disorders is an important line of research [13].
According to FAO, prebiotics are ‘non-viable food components
that confer a health benefit on the host associated with modulation
of the microbiota [14]. This concept has been thoroughly revised
and since most studied prebiotics are fibers, the latest definition
recognizes that prebiotics are ‘selectively fermented ingredients
that promote the selective stimulation of growth and/or activities
of one or a limited number of microbial genus(era)/species in the
gut microbiota that confer(s) health benefits to the host’ [15,16].
Plant extracts enriched in bioactive compounds are also widely
investigated as an additional strategy to combat obesity and
metabolic disorders since some of their components and (or)
derived metabolites appear to exert a number of metabolic
regulatory and anti-inflammatory properties as well as to modify
the intestinal environment through modulation of the microbiota
[17]. We have previously reported that a rosemary (Rosmarinus
officinalis, Lamiaceae) extract (RE) enriched in the bioactive
compound carnosic acid (CA) has body weight, serum lipids and
insulin lowering effects in female Zucker rats, more noticeable in
the lean animals. These effects were partially attributed to the
inhibition of a pre-duodenal butyrate esterase activity and
potential reduction of fat absorption [18]. We have also shown
that the RE differentially modulates the production of anti- and
pro-inflammatory cytokines as well as hepatic metabolic gene
expression in the lean and obese animals [19] but, the mechanisms
triggering these effects and the differences found between the two
genotypes are not yet fully understood.
To gain further insight into the potential mechanisms by which
the RE rich in CA may regulate energy metabolism and
inflammatory status as well as to further understand the different
response found between lean and obese Zucker rats [18,19], we
have examined changes in representative groups of Firmicutes,
Bacteroidetes and Actinobacteria present in the caecum of obese
(fa/fa) female Zucker rats and of their lean (fa/+) counterparts
following diet supplementation with the RE for 64 days. In
addition, we have measured and compared the effects of the RE
on caecum b-glucosidase activity and on the content of water and
macronutrients (fat, protein, ash and fiber) as well as SCFA in the
fecal output between the two types of animals.
Materials and Methods
Materials
The RE used in this study (reference GAX00011 batch number
A273/045/A10) was kindly provided by Naturex (Valencia, Spain)
and was prepared according to a patented method [20]. The
patented extract contains water (2.2%), fat (7.9%), protein (0.6%),
ash (6.2%), carbohydrates (29.1%), total dietary fiber (1%), CA
(38.961.7%), carnosol (6.560.1%) and CA 12-methyl ether
(6.960.6%). Other phenolic compounds were detected at very
small quantities and were not quantified (rosmarinic acid,
rosmanol epirosmanol, epiisorosmanol, epiisorosmanol ethyl
ether, rosmadial, caffeic acid hexoside, medioresinol, isorhamnetin
3-O-hexoside, homoplantagin, cirsimaritin and 49-methoxytecto-
chrysin) [21]. Porcine pancreatic a-amylase, soluble starch, 3,5-
dinitrosalicylic acid (DNS), p-nitrophenyl-b-D-glucopyranoside,
carnosic acid, carnosol, acetic acid (C2), propionic acid (C3),
isobutyric acid (i-C4), butyric acid (C4), isovaleric acid (i-C5),
valeric acid (C5), and 4-methyl valeric acid (internal standard) and
p-nitrophenol were all purchased from Sigma-Aldrich (St. Louis,
MO, USA) All other reagents were of chemical grade. Water was
deionized by using a Milli-Q-system (Millipore, Bedford, MA,
USA).
Animals and Experimental Design
This study was carried out at the Experimental Animal Unit of
the University of Murcia, Spain (Registration number: REGA ES
300305440012). All procedures were performed in strict accor-
dance with the European Union regarding animal experimenta-
tion (Directive of the European Council 86/609/EC and Spanish
RD 1201/2005). The protocols were approved by the Bioethics
Committee of the Department of Agriculture, Fisheries and
Livestock of the Autonomous Council of Government of Murcia,
Spain (Permit Number: C1311031102).
This study is a continuation of two previously published studies,
using the same animals and study protocol as previously described
[18,19]. Briefly, female Zucker lean (fa/+) (Le, n = 14) and obese
(fa/fa) (Ob, n = 10) rats (105.5613.3 g and 148.5622.9 g,
respectively) were fed with a standard diet (CT) or with the diet
supplemented with RE (0.5% w/w) for 64 days. Full diets
composition (major nutrients) is described in Table S1. Body
weight, food intake and feces weight were recorded throughout the
study. A total of 30 fecal stools per group of rats were scanned
using and ImageScanner II (Amersham Bioscience, General
Electric, Barcelona, Spain) and the Labscan v5.0 software. Images
were analyzed with the Microm Image Processing software (MIP
4.5, CID, Barcelona, Spain) and the maximum and minimum
diameters were measured. The volume (V) of the stools was
estimated using the formula for an ellipsoid V = 4/36p6a6b6c
(a = maximun diameter/2; b = c = minimum diameter/2). At the
end of the study (rats ,15-weeks old), non-fasted animals were
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anaesthetized by injection with a mixture (1:1, v/v; 1 mL/kg of
body weight) of ketamine (Imalgene 1000; Merial Laboratories,
Barcelona, Spain) and xylazine (Xilagesic 2%; Calier Laboratories,
Barcelona, Spain) and sacrificed by heart puncture exsanguina-
tion. The caecum and its contents were collected and weighed
(total weight). We removed the contents, washed the tissue
thoroughly and weighed again (tissue weight). The weight of the
contents was calculated by the difference between total and tissue
weight. All the samples were frozen in liquid nitrogen and stored at
280uC until further analysis.
Microbial analysis of the caecum contents
Quantitative PCR (qPCR) was performed to determine the
effect of the supplementation with RE on total bacteria counts and
on the composition of the caecum microbial community. Caecum
content (,20 mg) were added to 2 mL tubes containing special-
ized beads (MP Biomedicals, LLC, Ohio, USA) and homogenized
in the lysing matrix using the FastPrep Instrument (30 s, speed
setting of 5.5). DNA was then extracted using a commercial
extraction kit (QIAampR DNA Stool Mini Kit,Qiagen Inc.,
Valencia,CA) following the manufacturer’s instructions. qPCR
was performed using an ABI 7500 Sequence Detection System
(ABI, Applied Biosystems, Madrid, Spain). Metagenomic DNA
from dominant groups of fecal bacteria was quantified by real-time
qPCR with 16S rRNA species specific primers as indicated in
Table S2. Amplification and detection were carried out in 96-well
plates with TaqMan Universal PCR 26Master Mix (ABI) or with
SYBR-Green PCR 26Master Mix (ABI). Each reaction was run
in duplicate in a final volume of 25 mL with 0.20 mM final
concentration of each primer, 0.25 mM final concentration of each
probe and 10 mL of appropriate dilutions of DNA samples.
Amplifications were carried out using the following conditions: 1
cycle at 95uC for 10 min, followed by 40 cycles of 95uC for 30 s,
60uC for 1 min. For SYBR-Green amplifications, a melting step
was added to improve amplification specificity. Bacterial popula-
tion in the caecum samples were quantified using standard curves
made by serial dilution of known concentrations of genomic DNA
isolated from: Escherichia coli CECT 515T for total bacteria [22];
Bifidobacterium longum DSM 20088T for Bifidobacterium genus;
Lactobacillus plantarum CECT 748T for the quantification of
Lactobacillus/Leuconostoc/Pediococcus group; Clostridium leptum DSM
753T for the Clostridium leptum group; Blautia coccoides DSM 935T for
the Blautia coccoides/Eubacterium rectale group and Bacteroides ovatus
DSM 1896T for the Bacteroides/Prevotella group [23–25]. DNA from
pure cultures was isolated by using the DNeasy Blood & Tissue Kit
(Qiagen) following the manufacturer’s instructions. Standard
curves were prepared by plotting threshold cycles (Ct) vs. total
number of bacteria (CFU). Cell counts before DNA extraction
were determined by the standard plate count method. The caecum
content samples CFU were extrapolated from the averaged
standard curves (n = 3). Total bacteria are presented as the mean
log10 value per g of caecum content (fresh weight). Results for each
bacterial group are shown as relative abundance (%) of total
bacteria.
Fecal samples composition
The stools were rapidly frozen at 280uC and freeze-dried in a
lyophilizer (Alpha 1–4; Martin Christ, Osterode, Germany) for
48 h. Fecal water content was calculated by the weight difference
between fresh stools (weighed immediately after collection) and
dried stools. The dried stools were then ground and used for the
analysis of protein, fat, total dietary fiber and ash using the AOAC
official methods, 955.04, 920.39C, 985.29, and 923.03, respec-
tively [26].
Short-chain fatty acids analysis
SCFA levels were quantified according to a previously published
protocol [27]. Fecal samples were weighed and suspended in 1 mL
of water with 0.5% orthophosphoric acid per 0.1 g of sample and
frozen at 220uC. Once thawed, the fecal suspensions were
homogenized with a vortex for about 2 min and centrifuged for
10 min at 17,9496g. Supernatants were extracted with 1 volume
of ethyl acetate for 2 min and centrifuged for 10 min at 17,9496g.
Organic extracts were stored at 220uC. Prior to analysis, a
600 mL volume of the organic phase was transferred into a tube
and 4-methyl valeric acid added as internal standard (500 mM
final concentration). Samples were directly injected onto the GC-
MS column. The GC-MS system consisted of an Agilent 7890A
(Agilent Technologies, Palo Alto, CA, USA), equipped with an
automatic liquid sampler (MPS2) (Gerstel, Mu¨lheim, Germany)
and coupled to an Agilent 5975C mass selective detector. A fused
silica capillary column DB-WAXetr (30 m, 0.25 mm id, 0.25 mm
film thickness) and 1 mL/min of helium as carried gas were used
for the separation. Samples (1 mL) were injected in splitless mode
with an injector temperature of 250uC. The column temperature
was initially 90uC, then increased to 150uC at 15uC/min, to
170uC at 5uC/min, and finally to 250uC at 20uC/min and kept at
this temperature for 2 min (total time 14 min). Solvent delay was
3.5 min. The detector was operated in electron impact ionization
mode (electron energy 70 eV), scanning the 30–250 m/z range.
The temperature of the ion source, quadrupole, and interface were
230, 150, and 280uC, respectively. Identification of the SCFAs was
based on the retention times of the standard compounds and with
the assistance of the NIST 08 and Wiley7N libraries. A
characteristic single ion was selected for the quantification of each
compound: propionic acid 74, isobutyric acid 88, butyric acid 73,
isovaleric acid 87 and valeric acid 73.
Enzyme activity
a-Amylase activity. Small intestine content samples from
control and RE-supplemented lean rats were prepared as
previously described [18]. Pancreatic a-amylase was prepared in
ultrapure water (,1000 U/mL) immediately before use. Human
saliva samples were collected (n = 3 subjects) using a plastic Pasteur
pipette placed under the tongue for 30 s immediately before use.
Volunteers did not eat or drink anything for at least 30 min and
rinsed their mouth with water before saliva collection. Enzyme
reaction (final volume: 1 mL) was carried out in 20 mM sodium
phosphate buffer (6.7 mM NaCl, pH 6.9) containing 90 mL of the
substrate (1% boiled starch solution) tested against: i) 50 mL of
undiluted intestine content supernatant, ii) 10 U of pancreatic a-
amylase, or iii) 50 mL of human saliva. The reaction took place at
37uC for 20 min and thereafter 100 mL of DNS reagent solution
(32 mM DNS, 1 M sodium potassium tartrate in 0.4 M NaOH
solution) were added and samples were boiled for 15 min. Samples
were then cooled on ice, diluted 1:2 with ultrapure water and
absorbance recorded at 540 nm in an UV-VIS spectrophotometer
(Jasco V-630, Tokyo, Japan).
b-Glucosidase activity. b-Glucosidase activity was deter-
mined in the caecum digesta by measuring the rate of p-
nitrophenol release from p-nitrophenyl-b-D-glucopyranoside.
Caecum samples (,100 mg) were vortex mixed with 0.4 mL of
50 mM phosphate buffer (pH 6.5) and sonicated in ice for 15 min
followed by centrifugation at 16996g for 10 min. The reaction
mixture contained 20 mL of appropriately diluted caecum
supernatant in 50 mM phosphate buffer (pH 6.5) and 80 mL of
substrate solution (2 mM) and was incubated for 30 min at 37uC.
The reaction was stopped with 100 mL NaOH (0.5 M) and p-
nitrophenol quantified at 405 nm in 96-well plates in a microplate
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reader (Tecan Infinite M200, Tecan, Gro¨dig, Austria). Data were
collected in triplicate. Total protein content in the gut content
samples was measured by the DC colorimetric assay at 750 nm
(BioRad, Barcelona, Spain) based on a bovine serum albumin
standard curve.
CA (prepared in 4:1 ACN:DMSO, final solvent concentration
,10%) was added to the reaction mixtures to investigate the
specific effect of the compound on the gut content samples.
Enzyme activity was calculated as U/mg of protein.
Statistical analysis
Results are shown as the mean value 6 SD. Differences
between groups were compared using an unpaired Student’s t test.
Results with a two-sided P-value ,0.05 were considered
statistically significant. Principal component analysis (PCA) was
used to visualize the relationship between the caecum bacterial
groups examined in the Zucker lean and obese rats fed the control
diet or the diet supplemented with RE and the biochemical
variables (triglycerides, cholesterol, insulin, leptin, adiponectin,
tumor necrosis factor alpha (TNF-a), and interleukin 1 beta (IL-
1b)) previously determined in the serum of the same animals
[18,19]. All statistical analyses were performed using SPSS 19.0
for Windows.
Results
Effects of RE supplementation on body and caecum
weight
Final body weight for the lean CT rats was 229.6614.6 g
compared to 210.3615.0 g for the RE-supplemented lean group
(total body weight gain: 103.3 g vs. 80.1 g, respectively; P,0.01).
In the obese group, the final body weights were 455.2614.4 g for
the CT rats and 409.2631.4 for the RE-supplemented rats (total
body weight gain: 270.2 g vs. 235.0 g, respectively; P,0.05). Total
energy consumption was,1.7-fold higher in the obese rats than in
the lean ones (,75 vs. ,44 kcal/rat day) while the relative food
intake (RFI) was similar in the two genotypes and was not
significantly affected by the supplementation with the RE (Figure
S1).
We found that supplementation with the RE significantly
enlarged the size and weight of the caecum in lean and obese rats.
Relative values (g/100 g body weight) for total weight, caecum
content weight and organ weight are shown in Figure 1. Caecum
total weight was increased from 3.5460.23 g f.w. (fresh weight) in
the control lean rats to 6.6061.76 g f.w. (1.9-fold) in the rats
supplemented with the RE. In the obese rats, the caecum with its
contents weighed 4.5560.99 g f.w. in the control group and
6.3761.01 g f.w. (1.4-fold) in the RE-supplemented animals.
Microbial population changes associated with the RE
intake
qPCR analyses of the different groups of bacteria in the caecum
content samples obtained from lean and obese control rats as well
as from the RE-supplemented groups are shown in Figure 2 A–F.
Comparison between the control lean (CTLe) and obese (CTOb)
animals showed that the total numbers of bacteria were not
significantly different between the two genotypes (Figure 2A). We
detected, though, some significant differences between control lean
(CTLe) and obese (CTOb) rats for the specific groups of bacteria
examined: the relative abundance of the Bifidobacterium and of the
Lactobacillus/Leuconostoc/Pediococcus groups was higher in the obese
rats than in their lean counterparts (P,0.05) (Figure 2B and 2C,
respectively). We also detected that the C. leptum and Bacteroides/
Prevotella groups were lower (Figure 2D and 2F) and that the B.
coccoides group was higher in the obese control rats than in the lean
ones, although these results did not reach significance (P,0.1).
Supplementation with the RE caused a significant reduction of
total bacteria (Figure 2A) as well as of the Lactobacillus/Leuconostoc/
Pediococcus group (Figure 2C) whereas the B. coccoides was
significantly increased (Figure 2E), in both type of animals. The
Bacteroides/Prevotella group was also increased after the RE intake in
both genotypes, most significantly in the lean rats (Figure 2F).
Notably, the Bifidobacterium and C. leptum groups were significantly
increased and decreased, respectively, by the RE in the lean
animals (Figure 2B and 2D).
Discriminant PCA of the caecum bacterial groups in Zucker
female obese and lean rats and the serum lipids, adipokines and
cytokines previously measured in the same animals [18,19] is
shown in Figure 3. The analysis identified 2 components
accounting for 67% of the total variability. The first principal
component (PC1) explained 47% of the variability and was
determined by most of the serum variables (triglycerides,
cholesterol, leptin, insulin, TNF-a, and IL-1b) and by the
Lactobacillus/Leuconostoc/Pediococcus group (LAB). The second com-
ponent (PC2) explained 20% of the variability and was represented
mostly by the Bifidobacterium genus, the C. leptum and B. coccoides
groups, and adiponectin. The plot illustrates that, PC1 and PC2
clearly differentiate between the lean and the obese phenotypes
(P#0.001). PC1 and PC2 also discriminate between control and
RE-supplemented lean rats (P#0.001) but not between control
and supplemented obese rats. Thus, the intake of the RE causes a
marked different response between the lean and obese rats.
Effects of the RE supplementation on enzyme activity
Under the conditions of our assay, CA inhibited porcine
pancreatic a-amylase only at very high concentrations (,83%
inhibition at 100 mM CA and ,52% inhibition at 360 mM CA)
and did not show any effect on human salivary a-amylase at the
same concentrations. a-Amylase activity was slightly, but not
significantly, lowered in the small intestine of the animals that
consumed the RE (Figure 4). Rats supplemented with the RE
exhibited, however, a substantial reduction in caecum b-glucosi-
dase activity (96.1%, P= 0.005 in the obese animals and 92.2%,
P= 0.002 in the lean animals) (Figure 4). The addition of CA to
the reaction mixtures (final concentrations ,70–300 mM) did not
have any effect on the a-amylase or b-glucosidase activities.
Effects of RE supplementation on the fecal output
Total fecal weight (g) and fecal volume (mm3) were augmented
during the course of the experiment in the lean and obese rats
supplemented with the RE (Figure S2). Feces volume and weight
values at the end of the study are included in Table 1. Analysis of
the fecal macronutrients composition are also presented in Table 1
and provide evidence that the observed volume and weight
increment was mostly associated with a significant increase in the
water content (,1.3-fold) and of total fiber (,1.3–1.4-fold) in the
feces of the animals fed the RE-supplemented diet.
Fecal short-chain fatty acid changes induced by the RE
The concentration of total SCFA excreted in the feces was
higher in the control lean Zucker rats than in their obese
counterparts: 2145.66640.6 and 878.5672.4 mg/g (f.w.), respec-
tively. This difference was still observed after the values were
corrected by the daily fecal output (Table S3). The three major
SCFA were acetic, propionic and butyric acid (,90% of total)
(Figure 5) and the ratios acetate/propionate were not significantly
different between control Le and Ob rats (2.75 vs. 2.84,
respectively). Valeric, isovaleric and isobutyric were present in
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lower and more similar quantities in the two genotypes. The
consumption of the RE caused an increase in the three main
SCFA in the obese rats whereas in the lean rats, the levels of the
three SCFA were significantly reduced (Figure 5). These changes
were maintained after the values were corrected by the daily fecal
output (Table S3).The acetate/propionate ratio was slightly
reduced in both types of animals (2.0 and 1.79 for the RE-
supplemented lean and obese rats, respectively). The levels of
isobutyric, valeric and isovaleric acids were all slightly diminished
by the RE in both types of rats, most significantly in the lean rats.
Discussion
In the present study we have shown for the first time that
sustained consumption of a RE rich in the bioactive diterpenoid
CA selectively modified the growth of a limited number of bacteria
in the caecum: i) increased the B. coccoides and Bacteroides/Prevotella
groups and reduced the Lactobacillus/Leuconostoc/Pediococccus group
in lean and obese Zucker rats and, ii) increased the levels of the
Bifidobacterium genus and reduced those of the C. Leptum group,
most significantly, in the lean animals. In addition, the intake of
the RE reduced caecum b-glucosidase activity (.90%) and
increased the excretion of fecal fiber (7–8%) in the two types of
animals. These results are concomitant with the body weight
reducing effects and the metabolic and inflammatory beneficial
properties of the RE [18,19] and are suggestive of a potential
prebiotic effect of the RE against metabolic disorders and obesity.
Since most investigated prebiotics are fibers, it is important to
characterize and quantify the presence of fiber in bioactive
enriched plant extracts. Inulin, fructo-oligosaccharides, cellulose,
etc, are all prebiotics known to resist upper gut digestion and to
reach the large intestine where they are fermented by the
microbiota. The main site of bacterial fermentation in rats, the
caecum, is enlarged after the intake of these fibers [28,29]. The
consumption of the RE caused a significant augmentation of the
caecum weight suggesting the presence of additional non-digested
fibers and carbohydrates in the extract. However, considering that
the addition of the RE to the standard feed (0.5% w/w) did not
modify quantitatively the composition of the main nutrients in the
diet (Table S1) and that the RE did not affect the daily food intake
[18], the contribution of the RE to the daily consumption of fiber
and carbohydrates (as well as of the other nutrients) was minor (the
total fiber and carbohydrates provided by the RE accounted for as
little as ,0.03% of the total fiber and 0.3% of the carbohydrates
already present in the standard feed). Even if the fiber and
carbohydrates from the RE had not been digested in the small
intestine neither fermented in the caecum, they would not explain
the increase in the fiber excreted in the feces of the animals that
consumed the RE (,7–8%). However, we cannot fully discard
that some of the nutrients in the RE may have a part in the
observed effects. It should be noted that the major difference
between the two diets was the presence of diterpenoids which
provided a daily intake of these compounds of ,40 mg and
,70 mg for the lean and obese rats, respectively [18]. We have
previously shown that part of the ingested diterpenoids (CA,
carnosol, CA 12-methyl ether) resist gastric and small intestine
conditions and reach the large intestine [21] and therefore, it is
plausible that these molecules and (or) their derived metabolites
may be involved in the observed effects.
The evaluation of novel compounds or extracts with potential
prebiotic effects should also take into account the effects of such
products on digestive enzymes in the upper gut and in the
hydrolysis and fermentation by the microbiota in the large bowel.
We have previously reported that the intake of RE causes a
significant inhibition of a butyrate-esterase activity in the stomach
of Zucker rats and it was hypothesized that this may cause a
reduction in the digestion and absorption of fat from the diet [18].
Fecal composition analysis in the present work does not support
this hypothesis since we did not find significant differences in the
% of fat eliminated in the feces between the control and RE-
Figure 1. Effect of the RE-supplementation on full caecum, empty caecum and caecum content weight. Obese (Ob) and lean (Le) female
Zucker rats were fed a control diet (CT) or the diet supplemented with the rosemary extract (RE) enriched in carnosic acid (CA ,40%). Values are
expressed as g/100 g of body weight. Bars indicate mean values 6 SD (n = 7 lean animals, n = 5 obese animals per group). Significant differences
between control and RE-supplemented groups are also indicated: *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0094687.g001
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supplemented animals. We have now also evaluated the effects of
the consumption of the RE on a-amylase activity in the small
intestine and on b-glucosidase in the caecum of the rats. A number
of intestinal bacteria exhibit b-glucosidase activity, including
members of the saccharolytic Bifidobacteria, Lactobacilli and of
the Clostridial cluster XIVa (Eubacterium, Roseburia) [15,30]. Our
results show that the intake of the RE did not affect the rat
intestinal a-amylase activity. In contrast, the RE caused a
substantial reduction of the b-glucosidase activity in the caecum
of both the lean and obese animals suggesting that fermentation of
non-digested polysaccharides such as cellulose might be substan-
tially diminished. This was further supported by the significant
increase in the fiber excreted in the feces of the supplemented
animals. Fermentation of non-digested carbohydrates by saccha-
Figure 2. Box-and-Whisker plots of the content of bacteria in the caecum of obese (Ob) and lean (Le) female Zucker rats fed a
control diet (CT) or the diet supplemented with a rosemary extract (RE) enriched in CA (40%). Caecum content of: A) Total bacteria (T
bac) indicated as log10 of the value per gram of caecum content (fresh weight), B) Bifidobacterium genus, C) Lactobacillus/Leuconostoc/Pediococcus
group, D) Clostridium leptum group, E) Blautia coccoides group and F) Bacteroides-Prevotella group. Results for each group are presented as relative
abundance (%) of total bacteria. Horizontal lines represent the comparison between obese and lean rats. Significant differences are indicated by *P,
0.05, **P,0.01, ***P,0.001. P values below 0.1are also displayed as indication of a trend.
doi:10.1371/journal.pone.0094687.g002
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rolytic bacteria is currently considered a beneficial effect for host
metabolic health [15,16], and thus inhibition of this process may
be considered deleterious. However, fermentation in the caecum
produces a significant daily quantity of SCFA which are partially
assimilated into host carbohydrates and lipids equivalent to 8%
to10% of caloric requirements [8,9]. Inhibition of the enzyme
activities involved in this process such as b-glucosidase may
contribute to reduce dietary energy extraction and to moderate
body weight gain which may be beneficial. b-Glucosidases are also
de-glycosylating enzymes that can release a range of aglycones
from plant compounds which may exhibit toxic or health-
promoting activities [30]. The inhibition of this activity in the
caecum by the RE can thus have an additional impact on health
through regulation of bioactive microbial metabolites production.
It has been generally recognized that gut microbiota clearly
differs between, genetically- or diet-induced, lean and obese
phenotypes [3,4,31]. Genetic predisposition to obesity associated
to leptin (ob/ob mice) or leptin receptor (db/db mice) deficiencies
appear to shape a microbiota specialized for enhanced dietary
energy recovery with elevated abundance of Firmicutes and
reduced abundance of Bacteroidetes compared with lean mice
[12,32,33]. A closer look at the specific enriched or depleted genus
or species shows a significant variability depending on the
representative sequence used in the analysis [33] and on other
confounding factors (e.g. sex, age, diet composition, environmental
factors, etc) [5]. Leptin receptor-deficient Zucker male obese rats
[34] exhibited lower total bacteria but higher levels of Lab158
(most Lactobacillus, Leuconostoc and Pediococcus among other genus)
and Erec482 (most members of Clostridium cluster XIVa) and no
differences in Bac303 (most Bacteroides and Prevotella) compared to
Zucker male lean rats. In our study, the levels of total bacteria
were similar in the obese and lean female Zucker rats. We
corroborated that the obese rats displayed elevated numbers of
some members of the Firmicutes group, Lactobacillus/Leuconostoc/
Pediococcus and B. coccoides, compared with their lean counterparts
whereas the C. leptum and the Bacteroidetes groups were lower
(although did not reach significance) in the obese rats. The
saccharolytic Bifidobacterium genus, generally considered beneficial
bacteria, has also been inversely associated with obesity [3] but
while Waldram et al [34] confirmed lower levels of Bif164
(targeting most bifidobacteria) in the obese male Zucker rats, our
results show the opposite reinforcing the potential effects of other
variables in the microbiota (i.e. sex, diet, age, etc) and the difficulty
of establishing definitive differences between obese and lean
phenotypes. We also examined changes in some of the main
caecum microbiota groups following the intake of the RE. The RE
caused a moderate but significant reduction of total caecum
bacteria. It has been reported that germ-free mice and antibiotic-
treated mice display enlarged caecum and changes in the
proportions of Firmicutes and Bacteroidetes proportions [35–37]
which suggest that the RE might have a strain specific bactericidal
and/or bacteriostatic effect in the caecum. Indeed, CA and
carnosol exert some antimicrobial activities [38] and can be found
in the caecum of the Zucker rats following the intake of the RE
[21] and thus, we cannot discard a potential antibiotic effect of the
RE in the gut.
Many prebiotics (fibers) can improve glucose and lipid
homeostasis as well as the inflammatory status in the host and
these properties have been associated with the growth of beneficial
bacteria such as Bifidobacterium [4,16,31,39]. Dietary supplemen-
tation with the probiotic B. pseudocatenulatum CECT 7765 can
increase bifidobacteria in the gut and moderate serum lipids,
insulin resistance, leptin and other inflammatory cytokines in high-
fat fed mice [40]. In previous studies, we have shown that the
consumption of the RE rich in CA downregulated serum
triglycerides, cholesterol, insulin, leptin, TNF-a and Il-1b and
upregulated adiponectin [18,19] only in the lean Zucker rats
revealing critical regulatory differences against the leptin-resistant
obese rats. We now report that the consumption of RE is also
linked to a different response in the caecum Bifidobacterium counts
which are significantly increased in the lean animals and supports
an association with the regulation of lipids and adipokines in this
genotype. It should be noted that the numbers of Bifidobacterium
exhibited a large variability in the obese rats supplemented with
the RE. Although all the qPCR analyses were carried out
following the same protocols, under the same conditions and at the
Figure 3. Discriminant principal component analysis (PCA).
Analysis of the caecum bacterial groups in Zucker male obese (Ob) and
lean (Le) rats and the serum triglycerides, cholesterol, leptin, insulin,
adiponectin, TNF-a, and IL-1b previously measured in the same animals
[16,17]. Plot analysis of the four animal groups: control lean rats (CTLe,
open squares), RE-supplemented lean rats (RELe, black diamonds),
control obese rats (CTOb, open triangles) and RE-supplemented obese
rats (REOb, black circles).
doi:10.1371/journal.pone.0094687.g003
Figure 4. Effect of the RE-supplementation on gut enzyme
activity. a-Amylase activity in the small intestine and b-glucosidase
activity in the caecum of obese (Ob) and lean (Le) Zucker female rats.
Results are shown as % of inhibition respect to the activity in the
corresponding control (CT) group.
doi:10.1371/journal.pone.0094687.g004
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same time, we cannot fully discard the possibility of some qPCR
inhibitors in this group. However, the response of the obese
animals may be more variable since the obesity has been reported
to worsen or slow the capacity of these animals to respond to
nutritional or pharmacological treatment and thus, it may be more
difficult to exert a regulatory effect in these animals [41]. In
addition, we found that the C. leptum group was also differentially
regulated between the obese and lean genotype in response to the
RE. Principal component analysis of the current results for
bacterial groups and the previously reported serum biochemical
variables [18,19] (Figure 3) showed that these two genotypes could
be easily distinguished from each other and that the lean rats
responded to the RE more prominently than the obese ones.
Overall, our data support a host genetic effect in the gut
microbiota present in the lean and obese animals and that each
type of rat could have specific metabolic and inflammatory status
as well as different responses to dietary compounds linked to their
specific microbiomes [34].
Prebiotic fibers that promote fermentation lead, in general, to
higher levels of caecum and fecal SCFA [42]. These metabolites
act as mediators between gut microbiota and host inflammatory
status since they can function as signaling molecules suppressing
the production of inflammatory cytokines [43,44], regulating the
production of gut hormones such as glucagon-like peptide-1 (GLP-
1) and, consequently, insulin secretion [45] or inducing the
production of leptin [46]. The acetate/propionate ratio is also
critical in regulating cholesterol, lipids and glucose synthesis in the
host [47]. To determine whether the effects of the RE in the
caecum had an impact on the levels of SCFA, we analyzed the
concentration of these metabolites in feces. We found significant
differences between control lean and obese rats and between
control and RE-supplemented animals suggesting important
differences in the production, absorption and metabolism of these
metabolites between the two types of rats. Microbiota and SCFA
metabolism differences between the lean and obese Zucker rats
may be essential to explain the different metabolic and inflam-
Table 1. Estimated daily intake, total fecal output and percentage eliminated of main macronutrients in the obese (Ob) and lean
(Le) Zucker rats. Control group (CT) and rosemary extract (RE)-supplemented rats.
CTOb REOb CTLe RELe
Total daily intake (rat21 day21)a
Total energy (Kcal) 75.0610.9 71.967.1 43.969.6 43.864.1
Water (g) 21.7642.7 22.9641.0 19.7634.2 20.0641.1
Fat (mg) 1030 950 610 580
Protein (mg) 3698 3517 2165 2140
Ashes (mg) 1215 1163 712 708
Fiberb (mg) 5714 5462 3330 3308
Carbohydrates (mg) 12411 11836 7268 7203
Fecal daily output
Fecal volume (mm3) 247636 349659** 234631 288645**
Fecal weight (g, f. w.)c 5.4360.6 6.6460.4* 2.7760.2 3.6460.3*
Fecal composition
Water 60.1%d 61.8% 56.8% 58.3%
32616214e 41026164* 1573676 21236196*
(15.0%)f (17.9%) (7.9%) (10.6%)
Fat 1.1% 0.9% 1.2% 1.0%
57.862.7 58.061.6 32.061.5 35.567.2
(5.6%) (6.1%) (5.2%) (6.2%)
Protein 4.9% 4.5% 6.2% 4.4%
264.361.6 295.461.1 171.961.5 160.061.6
(7.2%) (8.4%) (7.9%) (7.5%)
Ashes 5.6% 4.4% 5.5% 4.4%
302.461.7 290.864.6 153.561.0 160.366.5
(24.9%) (25.0%) (21.3%) (22.6%)
Fiber 24.1% 24.7% 26.1% 28.0%
130761.6 163861.1* 72261.5 102261.6*
(22.9%) (30.0%) (21.7%) (30.1%)
Carbohydratesg 4.4% 3.9% 4.3% 3.9%
264.4 295.5 171.7 159.8
(2.13%) (2.49%) (2.36%) (2.22%)
a: values expressed per rat and per day and calculated using the average daily diet intake and diet composition presented in Table S1; btotal dietary fiber (AOAC 985.29);
c: f.w., fresh weight; d: g/100 fecal fresh weight; e: mg/rat day; f: (% eliminated with respect to daily intake); g: carbohydrates were estimated by difference; *: P,0.05 and
**: P,0.01 against the CT group.
doi:10.1371/journal.pone.0094687.t001
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matory response of the animals to the RE and warrant further
research.
Other plant extracts rich in bioactive compounds (e.g.
polyphenols), polyphenols themselves and/or their derived
metabolites have been shown to confer some of the effects
attributed to prebiotics [48]. A pomegranate extract, rich in
punicalagin and ellagic acid, increases caecum content and
Bifidobacterium and reduces serum cholesterol and the expression
of inflammatory markers in mice adipose tissue [49] and, both a
pomegranate extract and its main microbiota-derived metabolite
urolithin increase the counts of fecal Bifidobacterium, Lactobacillus
and Clostridium spp. and decrease inflammatory markers in the rat
[50]. Wild blueberry [51], green tea extracts [52] and resveratrol
[53] are all able to increase counts of Lactobacillus and/or
Bifidobacterium. Although some of these plant products need to be
fully characterized to determine or exclude the presence of
prebiotic fiber, these results and our results show that plant
bioactive compounds from different origins and molecular
composition or their derived metabolites are able to modify gut
microbiota composition and to promote beneficial changes with an
impact into the host metabolism and inflammatory response. It is
conceivable that plant food bioactive compounds may gradually
be considered or classified as ‘prebiotics’ or as compounds with
some ‘prebiotic effects’. The latest prebiotic concept [15,16] may
need to be expanded in the future to include these other food
components, even though they are not necessarily fermented by
the microbiota. Bioactive-enriched plant derived products consti-
tute an additional strategy to combat metabolic disorders and
associated inflammatory processes but further research is required
to fully characterize these products, to unravel their mechanisms of
action and to demonstrate their effects in humans.
In conclusion, a RE enriched in bioactive diterpenoids (mostly,
CA) and that exhibits body weight reducing effects and beneficial
metabolic and inflammatory properties [18,19] has also a
significant impact on the microbiota composition and b-glucosi-
dase activity in the caecum of female Zucker rats and increases
fiber fecal excretion. Importantly, the presence of a recessive
mutation in the leptin receptor (fa/fa, obese rats) has a critical
effect on the microbiota caecum composition and on the host
response to the consumption of RE. A limitation of our study is
that only a few groups of bacteria members of the Firmicutes,
Bacteroidetes, and Actinobacteria phyla were investigated and that
they constitute a small % of the total bacteria. With the application
of more potent technologies (metagenomics) and the identification
of new species of bacteria, we shall progressively know and
understand better the gut microbiota, its modulation by the diet
and its relationship with the host health status.
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Figure 5. Effect of the RE-supplementation on SCFA fecal composition. Results are shown as mg/g of feces f.w. (fresh weight) in obese (Ob)
and lean (Le) female Zucker rats fed a control (CT) diet or the diet supplemented with the rosemary extract (RE) rich in carnosic acid (CA, ,40%).
Significant differences between groups are indicated by *P,0.05, **P,0.01.
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